RECURRENT BREAST CANCER
Clinical trials for RECURRENT BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BREAST CANCER trials appear
Sign up with your email to follow new studies for RECURRENT BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat breast cancer: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug called alisertib combined with hormone therapy for people with a common type of advanced breast cancer (HR+, HER2-). It is for those whose cancer has worsened after at least two prior hormone treatments. The goal is to find the best dose and see if the…
Matched conditions: RECURRENT BREAST CANCER
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated May 26, 2026 07:32 UTC
-
New drug combo shows promise for tough breast cancer
Disease control Recruiting nowThis early-phase study tests two drugs, palbociclib and avelumab, together for people with a specific type of advanced breast cancer (AR+ triple-negative). The main goals are to find the safest doses and see if the combination can shrink tumors. About 45 participants with advance…
Matched conditions: RECURRENT BREAST CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated May 18, 2026 12:12 UTC